AKAP1 in Renal Patients with AHF to Reduce Ferroptosis of Cardiomyocyte
The Heart Surgery Forum · 2024
DOI: 10.59958/hsf.5717 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Heart Surgery Forum, 2024. Verfasst von Yifeng Fang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, The First People's Hospital of Yongkang, 321390 Yongkang, Zhejiang, China. yifengfang@yeah.net. Hauptthemen laut MEDLINE: Ferroptosis, Heart Failure, A Kinase Anchor Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Background
This study mainly investigated the mechanism and effects of AKAP1 in renal patients with acute heart failure (AHF).
Methods
Patients with renal patients with AHF and normal volunteers were collected. The left anterior descending arteries (LAD) of mice were ligated to induce myocardial infarction.
Results
AKAP1 messenger RNA (mRNA) expression was found to be down-regulated in renal patients with AHF. The serum levels of AKAP1 mRNA expression were negatively correlated with collagen I/III in patients. AKAP1 mRNA and protein expression in the heart tissue of mice with AHF were also found to be down-regulated in a time-dependent manner. Short hairpin (Sh)-AKAP1 promotes AHF in a mouse model. AKAP1 up-regulation reduces reactive oxygen species (ROS)-induced oxidative stress in an In Vitro model. AKAP1 up-regulation also reduces ROS-induced lipid peroxidation ferroptosis in an In Vitro model. AKAP1 induces NDUFS1 expression to increase GPX4 activity levels. AKAP1 protein interlinked with the NDUFS1 protein. Up-regulation of the AKAP1 gene reduced NDUFS1 ubiquitination, while down-regulation of the AKAP1 gene increased NDUFS1 ubiquitination in a model. In vivo imaging showed that the sh-AKAP1 virus reduced NDUFS1 expression in the heart of a mouse model.
Conclusions
AKAP1 reduced ROS-induced lipid peroxidation ferroptosis through the inhibition of ubiquitination of NDUFS by mitochondrial damage in model of renal patients with AHF, suggest a novel target for AHF treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Emergency, The First People's Hospital of Yongkang, 321390 Yongkang, Zhejiang, China. yifengfang@yeah.net.
- Department of Emergency, The First People's Hospital of Yongkang, 321390 Yongkang, Zhejiang, China. 815472447@qq.com.
- Department of Endocrine, The First People's Hospital of Yongkang, 321390 Yongkang, Zhejiang, China. huangruofei@hmc.edu.cn.
Zitieren
APA
Fang, Y., Xu, J., & Huang, R. (2024). AKAP1 in Renal Patients with AHF to Reduce Ferroptosis of Cardiomyocyte. The Heart Surgery Forum. https://doi.org/10.59958/hsf.5717
Vancouver
Fang Y, Xu J, Huang R. AKAP1 in Renal Patients with AHF to Reduce Ferroptosis of Cardiomyocyte. The Heart Surgery Forum. 2024. doi:10.59958/hsf.5717
BibTeX
@article{Fang2024,
author = {Fang, Yifeng and Xu, Junpeng and Huang, Ruofei},
title = {AKAP1 in Renal Patients with AHF to Reduce Ferroptosis of Cardiomyocyte},
journal = {The Heart Surgery Forum},
year = {2024},
doi = {10.59958/hsf.5717}
}
EUVIMED